BioSpace News Archive

Creating new sourcing, EryPharm envisions delivering red blood cells for transfusion.

The analysis shows that fibroids, which are often treated by hysteroscopic resection or morcellation, can be effectively treated with the Sonata ® System, the only incision-free, transcervical procedure that can treat most submucous, intramural, subserous, transmural and large fibroids

Company will work closely with Google Cloud and build AI tools for radiation oncology organ segmentation using the Google Cloud AI Platform

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), awarded the University of Missouri School of Medicine a bridge grant for $31,500 to continue evaluating CRISPR therapy in a pre-clinical model of Duchenne

2020, a record year with revenue of €13.5m, up 51% on 2019 2020 results in line with expectations Acceleration of the growth dynamic in the first quarter of 2021 with revenue of €5.2m, an increase of 86% compared to Q1, 2020.

Understanding how systemic racism affects the American healthcare system and how to identify it will be the message of this year’s keynote speaker at the upcoming National Kidney Foundation’s 2021 Spring Clinical Meetings.

BenevolentAI, a leader in the application of AI and machine learning in drug discovery and development, congratulate Eli Lilly on results from its COV-BARRIER trial in 1,525 hospitalised COVID-19 patients demonstrating baricitinib reduces mortality by 38% (nominal p-value=0.0018), showing the largest clinical effect reported to date for a reduction in mortality in this patient population.

The following is attributed to Acting FDA Commissioner Janet Woodcock, M.D., and Susan T. Mayne, Ph.D., director of the FDA’s Center for Food Safety and Applied Nutrition.

Control Bionics, a global assistive technology company specializing in speech generating devices, announced it is partnering with Numotion, a leading provider of Complex Rehab Technology (CRT) to offer the Control Bionics’ Trilogy product line.

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2021 financial results on Wednesday, April 28, 2021 prior to market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.